1. Home
  2. SNPS vs ZTS Comparison

SNPS vs ZTS Comparison

Compare SNPS & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPS
  • ZTS
  • Stock Information
  • Founded
  • SNPS 1986
  • ZTS 1952
  • Country
  • SNPS United States
  • ZTS United States
  • Employees
  • SNPS N/A
  • ZTS N/A
  • Industry
  • SNPS EDP Services
  • ZTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNPS Technology
  • ZTS Health Care
  • Exchange
  • SNPS Nasdaq
  • ZTS Nasdaq
  • Market Cap
  • SNPS 72.3B
  • ZTS 75.1B
  • IPO Year
  • SNPS 1992
  • ZTS 2013
  • Fundamental
  • Price
  • SNPS $470.53
  • ZTS $157.13
  • Analyst Decision
  • SNPS Strong Buy
  • ZTS Buy
  • Analyst Count
  • SNPS 14
  • ZTS 8
  • Target Price
  • SNPS $602.14
  • ZTS $211.50
  • AVG Volume (30 Days)
  • SNPS 1.6M
  • ZTS 2.8M
  • Earning Date
  • SNPS 05-28-2025
  • ZTS 08-05-2025
  • Dividend Yield
  • SNPS N/A
  • ZTS 1.27%
  • EPS Growth
  • SNPS 51.03
  • ZTS 7.32
  • EPS
  • SNPS 13.85
  • ZTS 5.57
  • Revenue
  • SNPS $6,221,316,000.00
  • ZTS $9,286,000,000.00
  • Revenue This Year
  • SNPS $12.51
  • ZTS $3.54
  • Revenue Next Year
  • SNPS $12.39
  • ZTS $6.11
  • P/E Ratio
  • SNPS $33.99
  • ZTS $28.22
  • Revenue Growth
  • SNPS 7.50
  • ZTS 6.32
  • 52 Week Low
  • SNPS $365.74
  • ZTS $139.70
  • 52 Week High
  • SNPS $624.80
  • ZTS $200.33
  • Technical
  • Relative Strength Index (RSI)
  • SNPS 44.21
  • ZTS 39.98
  • Support Level
  • SNPS $473.75
  • ZTS $154.54
  • Resistance Level
  • SNPS $484.53
  • ZTS $168.83
  • Average True Range (ATR)
  • SNPS 11.31
  • ZTS 3.41
  • MACD
  • SNPS -2.84
  • ZTS -1.67
  • Stochastic Oscillator
  • SNPS 30.31
  • ZTS 12.41

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: